Entrepreneurs and scientists gathered at Stanford recently to discuss how to use scientific discoveries to launch startups and improve patient care.
Certain brain tumors wire themselves into the brain's electrical communication network, a new Stanford-led study has shown.
Scientists found a sneaky way to stop cold viruses from replicating in mammalian cells by disabling a protein not in the virus but in the cells they infect.
At a recent talk on campus, Amy Abernethy, an FDA principal deputy commissioner, discussed her career and her work to facilitate clinical advances.
Stanford scientists have conducted a proof-of-concept experiment in mice that shows they can use blood stem cells to treat a severe brain disease.
Mammalian cells use a label to distinguish self from non-self circular RNA molecules. Foreign molecules can trigger anti-cancer immune responses.
Researchers at Stanford have devised an algorithm that predicts how likely a diagnostic test, when repeated, will yield useful information.
Researchers at Stanford have created the ultimate consult, pulling from millions of de-identified patient records to better inform the health of others.
The new Stanford Medicine magazine examines value, with a focus on disease detection, patient-doctor relationships and the latest health technology.
The best time to get a flu shot is when you haven't had antibiotics recently, a new study has found, because healthy gut bacteria protect immunity.
Researchers have identified five types of concussions, which have different symptoms and initial treatments. All can disturb sleep.
The conclusion of this series examines the benefits, and drawbacks, of probiotics. Stanford researchers clarify whether probiotics really improve health.
This two-part series examines the benefits, and drawbacks, of probiotics. Stanford researchers clarify whether probiotics can really boost your health.
Teenagers exposed to common agricultural pesticides before birth had distinctive reductions in certain types of brain activity, a new study has found.
The Myc oncogene helps cancer cells stockpile the fat, or lipids, necessary for rapid growth. Blocking this activity causes human tumors in mice to shrink.
Scientists have used CRISPR-Cas9 gene editing technology to decipher the genes critical to the success of a type of cancer drug, antibody-drug conjugates.
